These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 6175310

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Pregnancy-associated alpha 2-glycoprotein in patients with gynecologic cancer].
    Sawada M, Matsui Y, Okudaira Y, Shimizu Y, Takayama K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):451-8. PubMed ID: 6854093
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Serum levels of carcinoembryonic antigen (CEA) and pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast cancer].
    Kimoto A, Uemura K, Egami T, Kawaguchi H, Goto H, Miyauchi Y, Yokoyama I.
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec 20; 17(8):2022-8. PubMed ID: 7169574
    [No Abstract] [Full Text] [Related]

  • 5. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients.
    Moskal TL, Huang S, Ellis LM, Fritsche HA, Chakrabarty S.
    Cancer Epidemiol Biomarkers Prev; 1995 Mar 20; 4(2):127-31. PubMed ID: 7742720
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical usefulness of serum procollagen-III-peptide in patients with solid tumor].
    Takahashi T, Takami H, Abe O, Ootake T, Kano S.
    Gan To Kagaku Ryoho; 1984 Jul 20; 11(7):1480-6. PubMed ID: 6204598
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Serologic breast cancer follow-up monitoring using pregnancy-associated alpha-2-glycoproteins].
    Bauer HW, Hasselblatt I, Husfeldt KJ, Bohn H.
    Chir Forum Exp Klin Forsch; 1977 Apr 20; ():69-72. PubMed ID: 87297
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer.
    Ogawa Y, Ishikawa T, Ikeda K, Nakata B, Sawada T, Ogisawa K, Kato Y, Hirakawa K.
    Clin Cancer Res; 2000 Oct 20; 6(10):4069-72. PubMed ID: 11051258
    [Abstract] [Full Text] [Related]

  • 18. Clinical evaluation of the new tumor marker TAG-72.
    Guadagni F, Roselli M, Ferroni P, Amato T, Colcher D, Greiner JW, Schlom J.
    Anticancer Res; 1991 Oct 20; 11(4):1389-94. PubMed ID: 1746895
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
    Hiramatsu K, Takahashi K, Yamaguchi T, Matsumoto H, Miyamoto H, Tanaka S, Tanaka C, Tamamori Y, Imajo M, Kawaguchi M, Toi M, Mori T, Kawakita M.
    Clin Cancer Res; 2005 Apr 15; 11(8):2986-90. PubMed ID: 15837752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.